Author:
Abe Fuminori,Aoyagi Takaaki
Reference106 articles.
1. Abe, F., Shibuya, K., Uchida, M., Takahashi, K., Horinishi, H., Matsuda, A., Ishizuka, M., Takeuchi, T., and Umezawa, H., 1984, Effect of bestatin on syngeneic tumors in mice. Gann 75: 89–94.
2. Abe, F., Shibuya, K., Ashizawa, J., Takahashi, K., Horinishi, H., Matsuda, A., Ishizuka, M., Takeuchi, T., and Umezawa, H., 1985, Enhancement of antitumor effect of cytotoxic agents by bestatin. J. Antibiot. 38: 411–414.
3. Abe, F., Hayashi, M., Horinishi, H., Matsuda, A., Ishizuka, M., Takeuchi, T., and Umezawa, H., 1986, Enhancement of a graft-versus-host reaction and delayed cutaneous hypersensitivity in mice by ubenimex. J. Antibiot. 39: 1172–1177.
4. Abe, F., Alvord, G., Koyama, M., Matsuda, A., and Talmadge, J. E., 1989a, Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases. Cancer Immunol. Immunother. 28: 29–33.
5. Abe, F., Schneider, M., Black, P.L., and Talmadge, J.E., 1989b, Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice. Cancer Immunol Immunother. 29: 231–236.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The mercapturic acid pathway;Critical Reviews in Toxicology;2019-11-26